Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06544720
PHASE1
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Sponsor: The Affiliated Hospital of Qingdao University
View on ClinicalTrials.gov
Summary
A multicenter, open, single arm dose escalation and dose expansion phase I study to evaluate the safety, tolerability, and efficacy of SCG142 TCR-T cells in Subjects with advanced HPV associated carcinomas.
Official title: A Phase 1 Clinical Study of Autologous TCR-T Cells (SCG142) Therapy for Advanced HPV Associated Carcinomas
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2023-08-02
Completion Date
2026-12-31
Last Updated
2024-08-09
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
SCG142 TCR-T cells
Monotherapy of SCG142
Locations (1)
The affiliated hosptial of qingdao university
Qingdao, Shandong, China